Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cardiovascular Risk, Myocardial Fibrosis and Heart Failure in Rheumatoid Arthritis: Screening and Prognosis

NCT03960515 is registered in ClinicalTrials.gov with Maria Betânia Almeida Dias Ferreira as lead sponsor.

NCT NCT03960515
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03960515 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cardiovascular Risk, Myocardial Fibrosis and Heart Failure in Rheumatoid Arthritis: Screening and Prognosis
Lead sponsor
Maria Betânia Almeida Dias Ferreira
Phase
Observational
Overall status
Completed
Start date
June 22, 2016
Completion date
May 7, 2019
Enrollment
400 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases, cardiovascular risk factor, heart failure, myocardium; injury, rheumatoid arthritis